MedTrace Logo

Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia

NCT03449693 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 214

Last updated 2018-03-05

No results posted yet for this study

Summary

Clinical Trial. Open label. Parallel Groups. The purpose of the study is to determine the efficacy of oral supplementation with magnesium oxide to reduce febrile neutropenia episodes in pediatric oncology patients treated with cisplatin-based chemotherapy.

Conditions

Interventions

DIETARY_SUPPLEMENT

Magnesium Oxide Supplement

Magnesium Oxide tablet

Sponsors & Collaborators

  • Hospital Infantil de Mexico Federico Gomez

    collaborator OTHER

  • Centro de Investigación y Estudios Avanzados del Instituto Politécnico Nacional

    collaborator UNKNOWN

  • Universidad Nacional Autonoma de Mexico

    lead OTHER

Principal Investigators

  • Osvaldo D Castelán, PhD · Universidad Nacional Autónoma de México. Facultad de Estudios Superiores Zaragoza

  • Miguel A Palomo, PhD · Hospital Infantil de México Dr. Federico Gómez

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
9 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-19
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03449693 on ClinicalTrials.gov